Clinical Trial Update: The Efficacy and Safety of Silodosin Singly or Combined With Ningmitai Capsules in the Treatment of Benign Prostatic Hyperplasia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the efficacy and safety of silodosin alone or with Ningmitai capsules for benign prostatic hyperplasia with lower urinary tract…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia with Lower Urinary Tract Symptoms

Drugs mentioned

• Ningmitai capsules
• Silodosin (Silodosin)

Snippet

Sponsor: Xintian Pharmaceutical | Conditions: Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms | Phase 4 | Status: RECRUITING